Kairos Pharma, LTD. (KAPA) reporting calendar
Kairos Pharma, LTD. files periodic reports with the SEC as KAPA on NYSE. Atlas tracks 7 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 14 Jul 2026 – 14 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 13 May 2026
- Reports on record
- 7
How this window is derived. Derived from this issuer's own filing history: 7 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open KAPA market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 13 May 2026 | 43 days | 0001493152-26-022796 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001493152-26-014159 |
| 10-Q | 30 Sep 2025 | 14 Nov 2025 | 45 days | 0001493152-25-023276 |
| 10-Q | 30 Jun 2025 | 12 Aug 2025 | 43 days | 0001641172-25-023167 |
| 10-Q | 31 Mar 2025 | 14 May 2025 | 44 days | 0001641172-25-010089 |
| 10-K | 31 Dec 2024 | 15 Apr 2025 | 105 days | 0001641172-25-004920 |
| 10-Q | 30 Sep 2024 | 14 Nov 2024 | 45 days | 0001493152-24-045671 |
Source: SEC EDGAR company submissions for CIK 0001962011. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.